Sign in →

JAK2 V617F, Exon 12 and Other Non-V617F Mutation Analysis (JAK2 NGS)

eDH Procedure Code(s)

LAB4321 JAK2 V617F, Exon12, and Other Non-V617F Mut

Test Information

Clinical indication: Erythrocytosis and specific concern for polycythemia vera; This Next Generation Sequencing based assay is intended to detect JAK2 p.V617F and other non-V617F Mutations in JAK2 exons 12, 13, 14, and 15.

Order Questions

LAB4321 JAK2 V617F, Exon12, and Other Non-V617F Mut
  • Indication for JAK2 NGS Study

Specimen Information

Specimen Type Specimen Source Acceptable Containers Minimum Test Volume (mL)
Blood Blood, Venous Lav4-R 1.0
Blood Blood, Venous Lav6-R 1.0

Shipping and Handling

Processing Instructions: N/A

Transport Temperature: Refrigerated at 4°C
Transport Instructions: N/A

Specimen Stability Unprocessed
Unprocessed: Refrigerated at 4°C for 7 days
Specimen Stability Post Processing
Ambient: N/A
Refrigerate: N/A
Frozen: N/A

Test Components

Component LOINC Code
NGS REPORT STATUS 62364-5

Turnaround Time (TAT)

15 Days

CPT Code(s)

81279

Performing Lab Section

Molecular Pathology

Performing Lab(s)

Dartmouth Hitchcock Medical Center Laboratory (MHMH)